Alpha-mangostin as a new therapeutic candidate for concanavalin a-induced autoimmune hepatitis: impact on the sirt1/nrf2 and nf-b crosstalk

HIGHLIGHTS

  • who: Ahmed M. Shehata and collaborators from the Department of Pharmacology and Toxicology, College of Pharmacy, Taibah University, Al-Madinah Al-Munawwarah, Saudi Arabia have published the research: Alpha-Mangostin as a New Therapeutic Candidate for Concanavalin A-Induced Autoimmune Hepatitis: Impact on the SIRT1/Nrf2 and NF-B Crosstalk, in the Journal: Plants 2022, 11, 2441. of /2022/
  • what: The results of this study demonstrated a new therapeutic potential for u03b1-MN as it exhibited beneficial effects on Con A-induced AIH shown by the marked reduction in the serum indices of the hepatic . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?